Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso
Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond to epidemics. The authors of this article, published in Vaccine, evaluated the cost, including the cost per vaccinated versus non-vaccinated person, and impacts to the public health system of the 2007 epidemic bacterial meningitis season in Burkina Faso. They conclude that preventive meningococcal conjugate vaccines contribute to a more efficient use of funds dedicated to meningitis epidemics and limit the disruption of routine health services. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A. Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso. Vaccine. 2011;29(33):5474–5480.